Seaweed symbionts reveal treasure trove of potential drug compounds

Marine macroalgae-associated Bacillota reveal a trove of bioactive compounds with potential pharmacological benefits, from antibacterial to anticancer properties. This comprehensive review illuminates the promising yet underexplored therapeutic applications of these marine microorganisms.

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology – Biotech Investments

Issuer: Immunic AG / Key word(s): Scientific publication 13.11.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Announces

November 14, 2024

ESC 2024: Insights into RNA as therapeutic target and tool – Pharmaceutical Technology

Drs. Dimmeler, Giacca, and Rayner spoke on the last day of the European Society of Cardiology (ESC) Congress 2024 about the promise of RNA therapies

September 7, 2024

Opinion | Emotional CPR as an Alternative to Coercive Mental Health Treatment

Fisher is a psychiatrist. Several months ago, I interviewed the late Sally Zinman, a heroine of our mental health movement of people with lived experience.

September 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.